After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Dupixent® (dupilumab) U.S. Label Updated with Data Further Supporting Use in Atopic Dermatitis with Moderate-to-Severe Hand and Foot Involvement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Regeneron Pharmaceuticals, Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $933.40 and fluctuated between $937.99 as its day high and $928.65 as its day low. The current market capitalization of Regeneron Pharmaceuticals, Inc. is $101.69B. A total of 0.71 million shares were traded on the day, compared to an average of 565.82K shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, REGN has seen 2 BUY and 25 SELL insider trades, representing the acquisition of 21,000 and the disposition of 23,430 shares. Over the last 12 months, there were 29 BUYs and 184 SELLs from insiders. Insiders purchased 252,052 shares during that period but sold 284,982.
In the most recent transaction, Bassler Bonnie L sold 826 shares of REGN for 914.00 per share on Jan 03. After the transaction, the Director now owns 1,382 company shares. In a previous transaction on Jan 02, YANCOPOULOS GEORGE sold 16,848 shares at 900.00 per share. REGN shares that Bd. Co-Chair, President & CSO owns now total 180,000.
Among the insiders who sold shares, Zoghbi Huda Y disposed of 1,117 shares on Jan 02 at a per-share price of $900.00. This resulted in the Director holding 1,247 shares of REGN after the transaction. In another insider transaction, McCourt Marion sold 274 shares at $873.91 per share on Jan 02. Company shares held by the EVP Commercial now total 15,062.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for REGN in the last 3 months, the mean price target is $961.63 with high estimates of $1,125.00 and low estimates of $700.00. In terms of 52-week highs and lows, REGN has a high of $943.00 and a low of $684.80.
As of this writing, REGN has an earnings estimate of $10.94 per share for the current quarter. EPS was calculated based on a consensus of 20 estimates, with a high estimate of $13.48 per share and a lower estimate of $7.53. The company reported an EPS of $10.24 in the last quarter, which was 4.10% higher than expectations of $9.84.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. REGN’s latest balance sheet shows that the firm has $5.69B in Cash & Short Term Investments as of fiscal 2021. There were $2.70B in debt and $3.93B in liabilities at the time. Its Book Value Per Share was $228.90, while its Total Shareholder’s Equity was $18.77B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for REGN is Buy with a score of 4.43.
